Lexicon Pharmaceuticals
LXRX
#7233
Rank
NZ$0.83 B
Marketcap
NZ$2.30
Share price
1.52%
Change (1 day)
83.03%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.19 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has NZ$0.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.42 B56.93%
2023-12-31NZ$0.26 B23.38%
2022-12-31NZ$0.21 B71.6%
2021-12-31NZ$0.12 B-39.82%
2020-12-31NZ$0.21 B-47.68%
2019-12-31NZ$0.40 B69.05%
2018-12-31NZ$0.23 B-45.47%
2017-12-31NZ$0.43 B-12.52%
2016-12-31NZ$0.50 B-34.33%
2015-12-31NZ$0.76 B75.88%
2014-12-31NZ$0.43 B175.62%
2013-12-31NZ$0.15 B-42.09%
2012-12-31NZ$0.27 B-24.82%
2011-12-31NZ$0.36 B31.9%
2010-12-31NZ$0.27 B22.3%
2009-12-31NZ$0.22 B25.93%
2008-12-31NZ$0.17 B-47.4%
2007-12-31NZ$0.33 B197.51%
2006-12-31NZ$0.11 B-22.15%
2005-12-31NZ$0.14 B18.87%
2004-12-31NZ$0.12 B-23.33%
2003-12-31NZ$0.16 B-10.52%
2002-12-31NZ$0.17 B-50.4%
2001-12-31NZ$0.36 B-21.15%
2000-12-31NZ$0.45 B2510.2%
1999-12-31NZ$17.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
NZ$5.23 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$14.51 B 7,182.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ$0.73 B 266.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.53 B 1,174.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$6.09 B 2,958.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.15 B-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.19 B 1,002.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$1.16 B 483.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.29 B 48.74%๐Ÿ‡บ๐Ÿ‡ธ USA